AAAAAA
Results: 1-25/49
Authors:
HAGIWARA A
SAKAKURA C
SHIRASU M
YAMASAKI J
TOGAWA T
TAKAHASHI T
MURANISHI S
HYON S
IKADA Y
Citation: A. Hagiwara et al., THERAPEUTIC EFFECTS OF 5-FLUOROURACIL MICROSPHERES ON PERITONEAL CARCINOMATOSIS INDUCED BY COLON-26 OR B-16 MELANOMA IN MICE, Anti-cancer drugs, 9(3), 1998, pp. 287-289
Authors:
QUAN YS
HATTORI K
LUNDBORG E
FUJITA T
MURAKAMI M
MURANISHI S
YAMAMOTO A
Citation: Ys. Quan et al., EFFECTIVENESS AND TOXICITY SCREENING OF VARIOUS ABSORPTION ENHANCERS USING CACO-2 CELL MONOLAYERS, Biological & pharmaceutical bulletin, 21(6), 1998, pp. 615-620
Authors:
FUJITA T
KAWAHARA I
QUAN YS
HATTORI K
TAKENAKA K
MURANISHI S
YAMAMOTO A
Citation: T. Fujita et al., PERMEABILITY CHARACTERISTICS OF TETRAGASTRINS ACROSS INTESTINAL MEMBRANES USING THE CACO-2 MONOLAYER SYSTEM - COMPARISON BETWEEN ACYLATION AND APPLICATION OF PROTEASE INHIBITORS, Pharmaceutical research, 15(9), 1998, pp. 1387-1392
Authors:
UCHIYAMA T
KOTANI A
KISHIDA T
TATSUMI H
OKAMOTO A
FUJITA T
MURAKAMI M
MURANISHI S
YAMAMOTO A
Citation: T. Uchiyama et al., EFFECTS OF VARIOUS PROTEASE INHIBITORS ON THE STABILITY AND PERMEABILITY OF [D-ALA(2),D-LEU(5)]ENKEPHALIN IN THE RAT INTESTINE - COMPARISONWITH LEUCINE-ENKEPHALIN, Journal of pharmaceutical sciences, 87(4), 1998, pp. 448-452
Authors:
FUJITA T
TAMURA T
YAMADA H
YAMAMOTO A
MURANISHI S
Citation: T. Fujita et al., PHARMACOKINETICS OF MITOMYCIN-C (MMC) AFTER INTRAPERITONEAL ADMINISTRATION OF MMC-GELATIN GEL AND ITS ANTITUMOR EFFECTS AGAINST SARCOMA-180BEARING MICE, Journal of drug targeting., 4(5), 1997, pp. 289-296
Authors:
HAGIWARA A
SAKAKURA C
TSUJIMOTO H
IMANISHI T
OHGAKI M
YAMASAKI J
SAWAI K
TAKAHASHI T
FUJITA T
YAMAMOTO A
MURANISHI S
IKADA Y
Citation: A. Hagiwara et al., SELECTIVE DELIVERY OF 5-FLUOROURACIL (5-FU) TO IP TISSUES USING 5-FU MICROSPHERES IN RATS, Anti-cancer drugs, 8(2), 1997, pp. 182-188
Authors:
SUGIYAMA T
YAMAMOTO A
KAWABE Y
UCHIYAMA T
QUAN YS
MURANISHI S
Citation: T. Sugiyama et al., EFFECTS OF VARIOUS ABSORPTION ENHANCERS ON THE INTESTINAL-ABSORPTION OF WATER-SOLUBLE DRUGS BY IN-VITRO USSING CHAMBER METHOD - CORRELATIONWITH AN IN-SITU ABSORPTION EXPERIMENT, Biological & pharmaceutical bulletin, 20(7), 1997, pp. 812-814
Authors:
OKUMURA S
TANAKA H
SHINSAKO K
ITO M
YAMAMOTO A
MURANISHI S
Citation: S. Okumura et al., EVALUATION OF DRUG ABSORPTION AFTER INTRAPULMONARY ADMINISTRATION USING XENOPUS PULMONARY MEMBRANES - CORRELATION WITH IN-VIVO PULMONARY ABSORPTION STUDIES IN RATS, Pharmaceutical research, 14(9), 1997, pp. 1282-1285
Authors:
SASAKI I
TAMURA T
SHIBAKAWA T
FUJITA T
MURAKAMI M
YAMAMOTO A
MURANISHI S
Citation: I. Sasaki et al., METABOLISM OF AZETIRELIN, A NEW THYROTROPIN-RELEASING-HORMONE (TRH) ANALOG, BY INTESTINAL MICROORGANISMS, Pharmaceutical research, 14(8), 1997, pp. 1004-1007
Authors:
MURANISHI S
YAMAMOTO A
Citation: S. Muranishi et A. Yamamoto, THEME TITLE - RECTAL DRUG-DELIVERY - PREFACE, Advanced drug delivery reviews, 28(2), 1997, pp. 171-171
Authors:
YAMAMOTO A
MURANISHI S
Citation: A. Yamamoto et S. Muranishi, RECTAL DRUG-DELIVERY SYSTEMS - IMPROVEMENT OF RECTAL PEPTIDE ABSORPTION BY ABSORPTION ENHANCERS, PROTEASE INHIBITORS AND CHEMICAL MODIFICATION, Advanced drug delivery reviews, 28(2), 1997, pp. 275-299
Authors:
MURANISHI S
FUJITA T
MURAKAMI M
YAMAMOTO A
Citation: S. Muranishi et al., POTENTIAL FOR LYMPHATIC TARGETING OF PEPTIDES, Journal of controlled release, 46(1-2), 1997, pp. 157-164
Authors:
MURANISHI S
Citation: S. Muranishi, DELIVERY SYSTEM-DESIGN FOR IMPROVEMENT OF INTESTINAL-ABSORPTION OF PEPTIDE DRUGS, Yakugaku zasshi, 117(7), 1997, pp. 394-414
Authors:
FUJITA T
MORISHITA Y
ITO H
KURIBAYASHI D
YAMAMOTO A
MURANISHI S
Citation: T. Fujita et al., ENHANCEMENT OF THE SMALL-INTESTINAL UPTAKE OF PHENYLALANYLGLYCINE VIAA H+ OLIGOPEPTIDE TRANSPORT-SYSTEM BY CHEMICAL MODIFICATION WITH FATTY-ACIDS/, Life sciences, 61(25), 1997, pp. 2455-2465
Authors:
TOZAKI H
EMI Y
HORISAKA E
FUJITA T
YAMAMOTO A
MURANISHI S
Citation: H. Tozaki et al., DEGRADATION OF INSULIN AND CALCITONIN AND THEIR PROTECTION BY VARIOUSPROTEASE INHIBITORS IN RAT CECAL CONTENTS - IMPLICATIONS IN PEPTIDE DELIVERY TO THE COLON, Journal of Pharmacy and Pharmacology, 49(2), 1997, pp. 164-168
Authors:
YAMAMOTO A
OKAGAWA T
KOTANI A
UCHIYAMA T
SHIMURA T
TABATA S
KONDO S
MURANISHI S
Citation: A. Yamamoto et al., EFFECTS OF DIFFERENT ABSORPTION ENHANCERS ON THE PERMEATION OF EBIRATIDE, AN ACTH ANALOG, ACROSS INTESTINAL MEMBRANES, Journal of Pharmacy and Pharmacology, 49(11), 1997, pp. 1057-1061
Authors:
TOZAKI H
KOMOIKE J
TADA C
MARUYAMA T
TERABE A
SUZUKI T
YAMAMOTO A
MURANISHI S
Citation: H. Tozaki et al., CHITOSAN CAPSULES FOR COLON-SPECIFIC DRUG-DELIVERY - IMPROVEMENT OF INSULIN ABSORPTION FROM THE RAT COLON, Journal of pharmaceutical sciences, 86(9), 1997, pp. 1016-1021
Authors:
YAMAMOTO A
OKUMURA S
FUKUDA Y
FUKUI M
TAKAHASHI K
MURANISHI S
Citation: A. Yamamoto et al., IMPROVEMENT OF THE PULMONARY ABSORPTION OF (ASU(1,7))-EEL CALCITONIN BY VARIOUS ABSORPTION ENHANCERS AND THEIR PULMONARY TOXICITY IN RATS, Journal of pharmaceutical sciences, 86(10), 1997, pp. 1144-1147
Authors:
HAGIWARA A
SAKAKURA C
TSUJIMOTO H
OHGAKI M
IMANISHI T
YAMAZAKI J
SAWAI K
TAKAHASHI T
YAMAMOTO A
MURANISHI S
TABATA Y
IKADA Y
Citation: A. Hagiwara et al., NEW FORMULATION OF 5-FLUOROURACIL IN MICROSPHERES REDUCES TOXICITY INMICE, Anti-cancer drugs, 7(7), 1996, pp. 780-784
Authors:
UCHIYAMA T
YAMAMOTO A
HATANO H
FUJITA T
MURANISHI S
Citation: T. Uchiyama et al., EFFECTIVENESS AND TOXICITY SCREENING OF VARIOUS ABSORPTION ENHANCERS IN THE LARGE-INTESTINE - INTESTINAL-ABSORPTION OF PHENOL RED AND PROTEIN AND PHOSPHOLIPID RELEASE FROM THE INTESTINAL-MEMBRANE, Biological & pharmaceutical bulletin, 19(12), 1996, pp. 1618-1621
Authors:
OKUMURA S
FUKUDA Y
TAKAHASHI K
FUJITA T
YAMAMOTO A
MURANISHI S
Citation: S. Okumura et al., TRANSPORT OF DRUGS ACROSS THE XENOPUS PULMONARY MEMBRANE AND THEIR ABSORPTION ENHANCEMENT BY VARIOUS ABSORPTION ENHANCERS, Pharmaceutical research, 13(8), 1996, pp. 1247-1251
Authors:
FUJITA T
FUJITA T
MORIKAWA K
TANAKA H
IEMURA O
YAMAMOTO A
MURANISHI S
Citation: T. Fujita et al., IMPROVEMENT OF INTESTINAL-ABSORPTION OF HUMAN CALCITONIN BY CHEMICAL MODIFICATION WITH FATTY-ACIDS - SYNERGISTIC EFFECTS OF ACYLATION AND ABSORPTION ENHANCERS, International journal of pharmaceutics, 134(1-2), 1996, pp. 47-57
Authors:
YAMAMOTO A
FUJITA T
MURANISHI S
Citation: A. Yamamoto et al., PULMONARY ABSORPTION ENHANCEMENT OF PEPTIDES BY ABSORPTION ENHANCERS AND PROTEASE INHIBITORS, Journal of controlled release, 41(1-2), 1996, pp. 57-67
Authors:
MURANISHI S
FUJITA T
MURAKAMI M
YAMAMOTO A
Citation: S. Muranishi et al., LYMPHATIC TRANSFER OF MACROMOLECULES AFTER INTRAPULMONARY ADMINISTRATION IN THE PRESENCE OR ABSENCE OF VARIOUS ABSORPTION ENHANCERS IN RATS, Die Pharmazie, 51(5), 1996, pp. 331-336
Authors:
FUJITA T
YAMADA H
FUKUZUMI M
NISHIMAKI A
YAMAMOTO A
MURANISHI S
Citation: T. Fujita et al., CALCEIN IS EXCRETED FROM THE INTESTINAL MUCOSAL CELL-MEMBRANE BY THE ACTIVE-TRANSPORT SYSTEM, Life sciences, 60(4-5), 1996, pp. 307-313